Cross-sectional study shows non-invasive tests correlate with liver fibrosis in type 2 diabetes patients, indicating improved validity over ultrasound.
Key Points
To explore the effectiveness of non-invasive tests in assessing liver fibrosis among type 2 diabetes patients.
Cross-sectional study involving 120 patients with type 2 diabetes mellitus.
Assessment of liver fibrosis using FibroScan to measure liver stiffness.
Collection of serum-based markers and ultrasound scan results.
Moderate or advanced fibrosis detected in 24.2% of patients.
Positive correlations found between liver stiffness measure and glycated hemoglobin, triglyceride, and cholesterol levels.
Non-invasive scores demonstrated better clinical validity than ultrasound in detecting liver fibrosis.